PET and PK analysis of the humanized monoclonal anti-VEGF antibody HuMV833. an EORTC-biological treatment development group phase I study

G. C. Jayson; J. Zweit; C. Mulatero; D. Hastings; P. Julyan; M. Ranson; J. Lawrance; A. McGown; A. Jackson; L. Halannsom; J. Wagstaff; G. Groenwegen; F. Lehmann; D. Levitt; T. Tang; H. Zweirzina

doi:10.1016/S0959-8049(01)80467-6

PET and PK analysis of the humanized monoclonal anti-VEGF antibody HuMV833. an EORTC-biological treatment development group phase I study

G. C. Jayson^*, J. Zweit, C. Mulatero, D. Hastings, P. Julyan, M. Ranson, J. Lawrance, A. McGown, A. Jackson, L. Halannsom, J. Wagstaff, G. Groenwegen, F. Lehmann, D. Levitt, T. Tang, H. Zweirzina

^*Corresponding author for this work

Division of Informatics, Imaging & Data Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	European Journal of Cancer
Volume	37
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1016/S0959-8049(01)80467-6
Publication status	Published - 1 Jan 2001

Access to Document

10.1016/S0959-8049(01)80467-6

Cite this

Jayson, G. C., Zweit, J., Mulatero, C., Hastings, D., Julyan, P., Ranson, M., Lawrance, J., McGown, A., Jackson, A., Halannsom, L., Wagstaff, J., Groenwegen, G., Lehmann, F., Levitt, D., Tang, T., & Zweirzina, H. (2001). PET and PK analysis of the humanized monoclonal anti-VEGF antibody HuMV833. an EORTC-biological treatment development group phase I study. European Journal of Cancer, 37(SUPPL. 1). https://doi.org/10.1016/S0959-8049(01)80467-6

@article{b545260bf3424aa5a7e5176f5361c213,

title = "PET and PK analysis of the humanized monoclonal anti-VEGF antibody HuMV833. an EORTC-biological treatment development group phase I study",

author = "Jayson, {G. C.} and J. Zweit and C. Mulatero and D. Hastings and P. Julyan and M. Ranson and J. Lawrance and A. McGown and A. Jackson and L. Halannsom and J. Wagstaff and G. Groenwegen and F. Lehmann and D. Levitt and T. Tang and H. Zweirzina",

year = "2001",

month = jan,

day = "1",

doi = "10.1016/S0959-8049(01)80467-6",

language = "English",

volume = "37",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier BV",

number = "SUPPL. 1",

}

Jayson, GC, Zweit, J, Mulatero, C, Hastings, D, Julyan, P, Ranson, M, Lawrance, J, McGown, A, Jackson, A, Halannsom, L, Wagstaff, J, Groenwegen, G, Lehmann, F, Levitt, D, Tang, T & Zweirzina, H 2001, 'PET and PK analysis of the humanized monoclonal anti-VEGF antibody HuMV833. an EORTC-biological treatment development group phase I study', European Journal of Cancer, vol. 37, no. SUPPL. 1. https://doi.org/10.1016/S0959-8049(01)80467-6

TY - JOUR

T1 - PET and PK analysis of the humanized monoclonal anti-VEGF antibody HuMV833. an EORTC-biological treatment development group phase I study

AU - Jayson, G. C.

AU - Zweit, J.

AU - Mulatero, C.

AU - Hastings, D.

AU - Julyan, P.

AU - Ranson, M.

AU - Lawrance, J.

AU - McGown, A.

AU - Jackson, A.

AU - Halannsom, L.

AU - Wagstaff, J.

AU - Groenwegen, G.

AU - Lehmann, F.

AU - Levitt, D.

AU - Tang, T.

AU - Zweirzina, H.

PY - 2001/1/1

Y1 - 2001/1/1

UR - http://www.scopus.com/inward/record.url?scp=33645464141&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(01)80467-6

DO - 10.1016/S0959-8049(01)80467-6

M3 - Article

AN - SCOPUS:33645464141

SN - 0959-8049

VL - 37

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - SUPPL. 1

ER -

PET and PK analysis of the humanized monoclonal anti-VEGF antibody HuMV833. an EORTC-biological treatment development group phase I study

Access to Document

Other files and links

Cite this